Concepedia

Bret Wacker

BW

Statistics

Publications

7

Citations

1.8K

H-Index

7

Active since

2002

Affiliations

Georgetown University(Current)

Bret Wacker is an author at Georgetown University specializing in medicine, pharmacology, and oncology.

Publications per year

2002–2012

7

Publications

7

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Michael J. Keating, Ian W. Flinn, Vinay Jain et al. · Blood · 2002 · 946 citations · Full text

, , +8

Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies

Bret Wacker, Tina Nagrani, Jacqueline Weinberg et al. · Clinical Cancer Research · 2007 · 383 citations

, , +16

Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine

K. R., Carl E. Freter, R Mercier et al. · Journal of Clinical Oncology · 2002 · 308 citations

, , +17

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer

Fred R. Hirsch, Fairooz F. Kabbinavar, Tim Eisen et al. · Journal of Clinical Oncology · 2011 · 78 citations · Full text

, , +17

The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy.

Frank C. Richardson, Geoffrey D. Young, Regina Sennello et al. · PubMed · 2012 · 54 citations

, , +17

1–5 of 7